https://journals.sagepub.com/doi/full/10.1177/2047487316670255 The AliveCor Heart Monitor is feasible and well-accepted by primary practice staff for the screening of atrial fibrillation during influenza vaccinations. The rising aging population will be associated with a doubling in the prevalence of atrial fibrillation (AF) in the next 20 years. AF increases the risk of stroke, with at least 1 in […]
AliveCor’s Kardia product was successful in helping a patient with a history of ischemic heart disease detect possible atrial fibrillation. Major adverse cardiac events like myocardial infarction, stroke, and arrhythmias may occur in patients without any warning. Remote patient monitoring is a useful healthcare delivery tool to help physicians predict such adverse cardiac events and […]
AliveCor’s smartphone-operated ECG device demonstrated excellent diagnostic accuracy for atrial fibrillation and atrial flutter in a primary care population. For many patients experiencing symptoms of cardiac arrhythmias, the primary care physician is their first point of contact. Performing a 12-lead ECG is necessary if a patient presents with symptoms of cardiac arrhythmias. But in some […]
The AliveCor Heart Monitor was able to detect symptomatic heart rhythms at a higher rate than by standard care alone among patients who presented to the Emergency Department with palpitations and pre-syncope. In patients who present to the Emergency Department (ED) with palpitations and pre-syncope, diagnosis of the underlying heart rhythm is challenging. This is […]
Ambulatory blood pressure (BP) measurement (ABPM) has demonstrated to be a more effective predictor of cardiovascular disease-related mortality than office BP measurement (OBPM). BP measurements taken in non-clinical settings have the potential to reduce the “white coat effect” on patients’ BP and to lower healthcare costs associated with hypertension misdiagnosis. In India, a recent survey […]